Losapres

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Losapres

What is Losapres?

Losapres is a pharmaceutical medication containing the active ingredient losartan potassium. It belongs to a class of drugs known as angiotensin II receptor antagonists (sometimes referred to as ARBs).

Mechanism of Action

The medication works by interfering with the action of a natural substance in the body called angiotensin II. Angiotensin II is a potent vasoconstrictor, meaning it causes blood vessels to narrow and tighten. By blocking the receptors for this substance, Losapres allows blood vessels to relax and widen. This process facilitates smoother blood flow and helps the heart pump more efficiently.

Primary Therapeutic Uses

Losapres is primarily utilized in the management of cardiovascular conditions. Its main applications include:

  • Hypertension Management: It is used to help lower high blood pressure, which is a key factor in reducing the long-term risk of cardiovascular events.
  • Renal Protection: In patients with type 2 diabetes and a history of hypertension, it may be used to help protect kidney function and slow the progression of kidney disease.
  • Stroke Risk Reduction: For individuals with high blood pressure and left ventricular hypertrophy (thickening of the heart muscle), it is used to help decrease the statistical likelihood of experiencing a stroke.

Characterization

Losapres is a systemic treatment that focuses on vascular resistance. Unlike some other classes of blood pressure medications, it does not typically affect the heart rate directly, but rather focuses on the structural tension of the circulatory system. It is formulated to provide consistent blood pressure control throughout a 24-hour period.

What side effects are possible with Losapres?

Possible Side Effects and Safety Information

The safety profile of Losapres (Losartan Potassium) is formally documented in government regulatory sources, classifying potential adverse reactions by frequency and the affected System Organ Class. This information provides a structured overview of the medicine’s risk characteristics, without offering clinical advice.

Classification of Adverse Reactions

The following table summarizes key adverse reactions according to their frequency classification as stated in official labeling:

Classification Examples of Documented Reactions
Common (ge 1/100 to <1/10) Dizziness (vertigo), headache, fatigue (asthenia), and upper respiratory tract infection.
Uncommon (ge 1/1,000 to <1/100) Palpitation, symptomatic hypotension, insomnia, abdominal pain, diarrhea, and rash.
Rare (ge 1/10,000 to <1/1,000) Serious reactions including angioedema (swelling of the face, lips, or throat), anaphylaxis, and hepatitis.

Safety Considerations and Constraints

Official labeling notes specific safety patterns and constraints. Effects like a drop in blood pressure (hypotension) may be more evident at the start of treatment or during dose escalation. Safety constraints include a contraindication for use in the second and third trimesters of pregnancy due to fetal risk, and for individuals with known hypersensitivity to Losartan. Additionally, specific safety considerations apply to patients with hepatic impairment and severe renal impairment due to altered drug exposure or physiological effects.

Overdose and Emergency Response

Overdose and When to Seek Help

Official government regulatory information outlines specific risks and required actions in the event of Losapres (Losartan) overdosage, based on documented clinical experience.

Documented Overdose Presentations

The most likely manifestations of Losapres overdose are related to the cardiovascular system, primarily presenting as hypotension (extremely low blood pressure) and tachycardia (fast heart rate). In some cases, bradycardia (slow heart rate) may also occur. These effects are the focus of emergency management.

Immediate Actions and Management

If an overdose is suspected or confirmed, emergency medical attention must be sought immediately. Contact emergency services or a local Poison Help line right away. This is critical for managing severe drops in blood pressure and other potentially life-threatening hemodynamic changes.

Management of Losapres overdose is primarily supportive and symptomatic, meaning treatment focuses on stabilizing the patient’s vital signs, especially correcting symptomatic hypotension. It is important to note that authoritative regulatory documents state that hemodialysis is not effective for removing Losartan or its active metabolite from the body, constraining the available advanced treatment options.

Overdose Component Official Regulatory Statement
Primary Risk Severe hypotension and altered heart rate.
Antidote Availability No known specific pharmacologic antidote.
Elimination Procedures Hemodialysis is ineffective.

Therapeutic Uses of Losapres

Losapres (Losartan) is generally considered relevant for managing chronic conditions that involve heightened systemic burden, focusing primarily on supporting general well-being during symptomatic phases and providing specific symptomatic support. Its use is centered on three main therapeutic domains.

This medication is commonly used to help with conditions like essential hypertension, in high-risk contexts associated with stroke risk (particularly in patients with left ventricular hypertrophy), and for managing kidney-related symptoms in adult patients with Type 2 Diabetes Mellitus and hypertension. Its application helps address symptom clusters that create noticeable physiological strain by managing consistently elevated blood pressure.

In these scenarios, Losapres supports the patient during difficult episodes by easing distress related to vascular strain and assists with maintaining functional stability.

Quick Fact: Relief for Systemic Pressure Imbalance


Management of Persistent High Blood Pressure

This medication is used for managing consistently elevated blood pressure, addressing symptoms related to systemic imbalance. This supportive approach generally assists with maintaining functional stability and contributes to easing the overall symptom load related to vascular strain.

Use in Clinical Contexts Involving Stroke Risk and Heart Strain

Losapres is applied in clinical settings for patients with conditions marked by increased physiological stress. Its use may assist with managing conditions associated with stroke risk and also supports patients during episodes of heightened discomfort related to cardiac strain. The medication is relevant for easing symptoms linked to organ-specific functional stress in cases of chronic heart failure.

Management of Kidney-Related Symptoms in Type 2 Diabetes

The medication is generally relevant for easing symptoms related to organ-specific functional stress, specifically in adult patients with Type 2 Diabetes Mellitus who have hypertension and early signs of diabetic nephropathy. This application helps address symptom clusters that create noticeable physiological strain and is commonly used across domains where additional symptomatic support is needed in this patient group.

Regulatory References

  1. DailyMed (NIH) Losartan Potassium tablet information

Eligibility and Restrictions for Use

Who Can and Cannot Use Losapres?

Eligibility for Losapres (Losartan Potassium) is defined by official regulatory criteria, classifying patient populations as permitted, restricted, or prohibited.


Contraindicated Populations

Use is contraindicated in patients with a known hypersensitivity to Losartan Potassium or formulation components, and in those with severe hepatic impairment. Losapres is also contraindicated during the second and third trimesters of pregnancy. Additionally, patients with diabetes mellitus or renal impairment (GFR < 60 mL/min/1.73 m^2) who are receiving medication containing aliskiren must not use Losapres.


Age and Physiological Restrictions

Adults are the primary approved population for all labeled uses. Use is generally not recommended during the first trimester of pregnancy or while breastfeeding. In pediatric patients, use is limited to essential hypertension in those aged 6 to 18 years but is not recommended in children under 6 years of age. Furthermore, use is not recommended for children with a GFR < 30 mL/min/1.73 m^2.


Conditional Use

Losapres may require precaution or adjustment in patients with mild-to-moderate hepatic impairment and those with existing volume or salt depletion (which often requires correction prior to initiation).

What should I know about interactions with other medicines?

Losapres Interactions with other medicines and products

Losapres (Losartan) interacts with several classes of medications and products, primarily affecting potassium balance and renal function.

Product Category Interaction Summary
Agents Increasing Serum Potassium Concomitant use with potassium-sparing diuretics, potassium supplements, or salt substitutes containing potassium may lead to a clinically significant risk of hyperkalemia (high blood potassium levels).
NSAIDs and COX-2 Inhibitors Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including selective COX-2 inhibitors, may reduce the blood pressure-lowering effect of Losapres. This combination may also increase the risk of renal function deterioration, particularly in elderly or volume-depleted patients.
Lithium Losapres can reduce the elimination of lithium, leading to increased lithium concentrations and a risk of toxicity. Serum lithium levels must be closely monitored if co-administration is necessary.
Dual RAS Blockade Combining Losapres with other Angiotensin Receptor Blockers (ARBs), ACE inhibitors, or Aliskiren is generally not recommended. Dual blockade of the Renin-Angiotensin System (RAS) is associated with increased risks of hypotension, hyperkalemia, and severe renal impairment. The use of Losapres with Aliskiren is contraindicated in patients with diabetes or moderate to severe kidney impairment.

Mechanism of Action

How Losapres Works

Receptor Interaction and Primary Pathway

Losapres modulates the A2 B receptor. Binding to this receptor results in reduced activation of the NFkappa B pathway, a crucial transcription factor signaling cascade.

Molecular and Cellular Cascade

The reduction in NFkappa B pathway activity directly modulates the differentiation and function of osteoclasts, the cells responsible for bone resorption. Inhibition of this signaling cascade subsequently alters the expression of specific genes involved in the breakdown of bone matrix.

Physiological Consequence

The resulting downstream effect is a shift in the ratio of osteoblast-to-osteoclast activity. This shift favors processes associated with bone anabolism over those related to bone resorption.

Dosage and Administration Information

How to Use Losapres — Administration Guidelines

Losapres (Losartan Potassium) is an oral medication with established dosing and administration guidelines for the management of chronic conditions.


Administration Scope

Feature Instruction Summary
Route of administration Oral (via tablet or prepared suspension)
Dosing schedule (Adults) Starting Dose: 50 mg once daily for most uses.
Maintenance/Maximum Dose: The dosage may be increased up to 100 mg once daily, based on response.
Timing in relation to meals May be administered with or without food.
Preparation requirements Oral tablets should be swallowed whole with water. A specialized oral suspension may be compounded for pediatric use, requiring specific preparation.
Age-group administration rules Pediatric (6–16 years): The starting dose is 0.7 mg/kg once daily, with a total dose not to exceed 50 mg. Not recommended for children under 6 or those with severe renal impairment.
Missed-dose rules If a dose is missed, patients should take the next dose at the usual time and not take a double dose to compensate.
Special procedural conditions Reduced Starting Dose: A lower starting dose of 25 mg once daily is recommended for patients with a history of hepatic impairment or those with possible intravascular volume depletion.

Instruction Classifications (High-Level)

Classification Value
Administration method type Oral
Frequency pattern Daily (Once daily)
Use-context constraints Requires dosage modification for specific patient physiological states (e.g., hepatic function) and strict adherence to a long-term daily schedule.

Resulting Procedural Structure

Step sequence:

  • Begin treatment with the appropriate dose (standard 50 mg or 25 mg for vulnerable populations) administered once daily.
  • Take the Losapres tablet or suspension orally, swallowing the tablet whole, independent of meal timing.
  • Maintain a consistent daily schedule, progressing the dose toward the maintenance or maximum of 100 mg if needed, over several weeks.

Connection to the Overall Use Protocol

The instructions establish a structured, once-daily, oral administration protocol, ensuring the drug is taken consistently over a chronic duration. This framework defines precise starting doses and maximum limits for adults and a weight-based regimen for children, all independent of food intake. The dose reductions for specific populations outline how the medicine is to be initially introduced under certain conditions.

Recent Clinical Evidence

Research Evidence / Overview of studies for Losapres


Evidence for use in Managing Persistent High Blood Pressure

Research has explored whether Losapres, in numerous short-term Randomized Controlled Trials (RCTs), was associated with changes in blood pressure, a condition characterized by outcomes related to systemic or functional imbalance. Research primarily examined adult populations with essential hypertension, with separate trials also evaluating its use in children aged 6 and older. These trials generally used follow-up durations of a few months to measure changes in systolic and diastolic blood pressure (BP) readings compared to placebo.

Findings describe patterns observed in these studies where BP measurements changed during the short study period. Losapres was evaluated against inactive placebo pills, and some studies examined it alongside other medications, with research describing differences in measured BP readings between the groups. However, the evidence from these initial trials is primarily based on short-term changes in BP levels, and the results apply only to the specific populations studied, often excluding patients with multiple complex health issues.


Evidence for use in Reducing Stroke Risk

Research examined Losapres in a very specific, high-risk group through large-scale, long-term outcome trials. These studies focused on adult patients who had hypertension along with Left Ventricular Hypertrophy (LVH). The primary focus of the research was monitoring major cardiovascular endpoints, specifically the time to the first occurrence of fatal or nonfatal stroke over several years. Data show patterns related to the incidence of stroke that was measured for patients who were observed with a Losapres-based therapy compared to those with a standard regimen of another class of medication. The results apply specifically to the high-risk group of patients with both hypertension and LVH, and subgroup findings are uncertain for certain racial or ethnic groups.


Evidence for use in Kidney-Related Symptoms in Type 2 Diabetes

Losapres was also studied for its use in adult patients who have Type 2 Diabetes Mellitus, pre-existing hypertension, and specific signs of diabetic kidney disease, a scenario involving outcomes related to functional limitations. Long-term outcome trials explored progression of the disease and the composite outcome of needing dialysis or transplantation. Studies described patterns related to the measured levels of proteinuria (protein in the urine) for the Losapres group. However, the research applied only to patients with Type 2 Diabetes and specific levels of hypertension; the primary trial reported that patterns related to total all-cause mortality were not found to be different between the Losapres group and the comparison group.

Key Studies & References

  1. Losartan Potassium tablet information (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Losapres (FAQ)


Q: What is the main difference between Losapres and similar drugs I see advertised?

Losapres is officially classified as an Angiotensin II Receptor Antagonist (ARB). This means it works by specifically blocking the AT1 receptor, which prevents the hormone Angiotensin II from causing blood vessels to narrow. Regulatory documents describe this mechanism as distinct from older blood pressure medications, such as ACE inhibitors.


Q: Are there any specific foods or drinks that should be avoided when taking Losapres?

Official instructions state that Losapres can generally be taken with or without food. Regulatory warnings emphasize caution regarding products that increase potassium levels. Combining Losapres with supplements, salt substitutes, or diuretics that contain potassium may pose an increased risk of high blood potassium levels, as noted in official product information.


Q: Do studies suggest any long-term effects of taking Losapres?

Official research evidence includes long-term outcome trials that have spanned several years. These studies primarily focused on the drug's long-term effectiveness in specific patient groups, such as reducing stroke risk or slowing the progression of kidney-related symptoms. The safety profile is monitored continuously throughout these long-term studies and post-market use.


Q: What should I do if I experience a rash while taking Losapres?

Regulatory documents list rash as an uncommon side effect of Losapres. The official safety information emphasizes that any new or concerning skin reaction should be discussed with a healthcare professional for evaluation.


Q: Does Losapres interact with common supplements like multivitamins or herbal products?

Regulatory information specifically warns about the risk of hyperkalemia (high blood potassium) when Losapres is combined with potassium supplements or certain salt substitutes. Official labeling does not typically standardize warnings for general multivitamins or other specific herbal products.


Q: Are there research studies looking into new uses for Losapres?

Regulatory records and clinical trial databases indicate that the drug's mechanism of action continues to be explored. Studies are ongoing to examine its potential role in new research areas beyond the labeled uses of high blood pressure and specific cardiovascular/kidney symptoms.


Q: How does Losapres affect kidney function?

Losapres is used to treat kidney-related symptoms in certain patients with diabetes and high blood pressure, as it helps relax blood vessels in the kidneys. However, official documents also caution that Losapres used alongside certain other medications (like NSAIDs) may increase the risk of renal function deterioration, particularly in vulnerable patients.


Q: What kind of monitoring tests are usually done when someone is on Losapres?

Official regulatory documents indicate that monitoring two key areas is typically recommended. This includes checking serum potassium levels and renal function (such as creatinine and blood urea nitrogen), particularly when starting treatment.


Q: What if I start to feel better—can I stop taking Losapres?

Losapres is intended for the long-term, chronic management of conditions like high blood pressure, which may not have obvious symptoms. Regulatory patient counseling information emphasizes that changes to the medication schedule should only be made after consulting a healthcare professional.


Q: If I travel to a hot climate, should I be more careful when taking Losapres?

Official safety information advises caution for patients with existing volume or salt depletion. Since excessive sweating in hot weather can lead to this condition, it is noted that such patients may require a lower initial dose or correction before beginning Losapres.


Q: What is the difference between the active and inactive ingredients in Losapres?

The active ingredient, Losartan Potassium, is the chemical compound that is responsible for the medication's therapeutic effects. Inactive ingredients (or excipients) are necessary substances added to the tablet to help stabilize the active component, control its release, and form the final product.


Q: Does Losapres affect blood sugar levels?

Losapres is frequently used to treat kidney-related symptoms in patients who have Type 2 Diabetes and high blood pressure. While it is used in this patient population, official documents do not indicate that Losapres itself directly causes changes in blood glucose or sugar levels.


Q: What does the term 'contraindication' mean for Losapres?

A contraindication is a specific regulatory term used to describe a circumstance or condition where the use of a drug is officially not recommended because it may be harmful. For Losapres, contraindications include conditions like pregnancy (second and third trimesters) or severe liver impairment.


Q: Can Losapres affect my ability to get pregnant or have children?

Regulatory documents focus primarily on the significant risk during pregnancy where Losapres is contraindicated in the second and third trimesters. Official labeling does not explicitly include specific warnings or restrictions regarding the drug’s potential effect on fertility (the ability to conceive) for men or women.


Q: Can Losapres be used for conditions other than what my doctor prescribed it for?

Losapres is approved for use in specific, labeled conditions, including high blood pressure, stroke risk reduction in specific patient groups, and kidney-related symptoms in Type 2 Diabetes. Regulatory documents do not provide information regarding use for conditions outside of these official indications.


Q: How quickly does Losapres start to show an effect?

Regulatory data on pharmacokinetics (how the body handles the drug) describes that the drug reaches its maximum concentration in the blood within 3 to 6 hours after administration. However, the full, maximum blood pressure-lowering effect may require three to six weeks of consistent daily use to fully develop.


Q: If Losapres is working, how will I know or feel a change?

For chronic conditions like high blood pressure, patients often do not feel an immediate or noticeable change when the drug is working. Regulatory patient counseling information emphasizes that the only way to know if the medicine is achieving its purpose is through monitoring measurements like blood pressure readings.


Q: Can older adults generally use Losapres?

Official regulatory documents confirm that Losapres is approved for use in the elderly population. Dosing adjustments are not typically required solely based on advanced age, though caution regarding other conditions common in older adults, such as volume depletion, is noted.


Q: Is Losapres the generic name or a brand name?

Regulatory listings confirm that Losartan Potassium is the official generic name for the active ingredient. Losapres is considered a brand name used to market the medication containing Losartan Potassium.


Q: Does Losapres have any known interactions with alcohol?

Official labeling advises that alcohol may increase the risk of hypotension (low blood pressure) when consumed with Losapres. This risk is due to alcohol's effect on blood pressure combined with the drug's action.


Q: Why is Losapres sometimes prescribed with a diuretic (water pill)?

Losapres is often combined with a diuretic (like HCTZ) because the combination has an additive blood pressure-lowering effect compared to Losapres alone. This therapeutic rationale is documented in the clinical pharmacology sections of official labeling.


Q: Does Losapres have a known 'black box warning' from the FDA?

The Losapres label includes a prominent Boxed Warning (often called a 'black box warning') from the FDA regarding the use of the drug during pregnancy. The warning states that drugs acting directly on the Renin-Angiotensin System can cause injury and death to the developing fetus.


Q: What is the general expectation for how long the effects of a single dose of Losapres last?

Regulatory information on pharmacokinetics indicates that the active component of Losapres has an elimination half-life of approximately 6 to 9 hours. This allows the drug to maintain its therapeutic action with a once-daily dosing schedule.


Q: Can I take Losapres if I have a history of asthma or breathing problems?

Official regulatory documents do not list asthma or breathing problems as a contraindication or required precaution for the use of Losapres. Contraindications are limited to conditions such as hypersensitivity and pregnancy.


Q: Are there specific times of day that Losapres is generally advised to be taken?

Regulatory instructions state that Losapres should be administered once daily to maintain a consistent schedule. Official documents do not specify a mandatory morning or evening time; the goal is simply consistent daily use.


Q: What do studies say about Losapres and driving ability?

Due to the potential for side effects such as dizziness or fatigue (both listed as common/uncommon effects), official information notes that the drug may have a minor influence on the ability to drive or use machinery, especially at the start of treatment.


Q: Can Losapres be crushed or split?

The official instructions for the tablet form advise that it should be swallowed whole with water. Regulatory information does not authorize crushing, splitting, or otherwise altering the tablet form for administration.


Q: If I have a medical procedure or surgery planned, should I temporarily stop Losapres?

Official documents advise caution regarding the potential for hypotension (low blood pressure) during surgery. Because Losapres blocks the Angiotensin II system, this topic should be discussed with the surgical team and anesthesiologist well in advance of the planned procedure.


Q: Are there common signs of too much Losapres in the body?

Regulatory information on overdose describes the most likely signs to be hypotension (extremely low blood pressure) and tachycardia (rapid heartbeat). Bradycardia (slow heartbeat) may also occur in some circumstances.


Q: Is Losapres considered a high-risk medication for falls in the elderly?

Due to the common side effect of dizziness and the potential for hypotension, Losapres carries an implicit risk of contributing to falls, particularly in older patients. This type of risk is often addressed in the Geriatric Use section of regulatory labeling.

How should Losapres be stored and disposed of?

Official Storage and Disposal Instructions

Losapres (Losartan Potassium) must be kept in its original, tightly closed container and stored at room temperature, away from excess heat, light, and moisture. The medication must not be stored in the bathroom and must be protected from freezing. To prevent accidental ingestion, the medicine must always be stored out of sight and reach of children, with all safety caps securely locked.

For any prepared or compounded oral suspension, the product has a limited shelf-life and must be refrigerated (2°C to 8°C or 36°F to 46°F) and discarded after a specific period (e.g., 4 to 8 weeks, depending on the formulation).

Disposal must be done responsibly. The official recommendation is to use a drug take-back program. If this is unavailable, the medication should be removed from its container, mixed with an undesirable substance like used coffee grounds or kitty litter, sealed in a bag or can, and placed into the household trash. The original prescription label should have all identifying information completely scratched out prior to discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Losapres found in:

A-Z Index: